MedPath

NYU LANGONE HEALTH

NYU LANGONE HEALTH logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Private
Established
1841-01-01
Employees
10K
Market Cap
-
Website
http://www.nyulangone.org

Safety of Estrogens in Lupus: Birth Control Pills

Phase 3
Completed
Conditions
Systemic Lupus Erythematosus
First Posted Date
1999-11-04
Last Posted Date
2013-05-03
Lead Sponsor
NYU Langone Health
Target Recruit Count
350
Registration Number
NCT00000420
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Louisiana School of Medicine, Dept. of Medicine/Immunology, Shreveport, Louisiana, United States

๐Ÿ‡บ๐Ÿ‡ธ

UCLA Medical Center, Dept. of Rheumatology, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago Pritzker School of Medicine, Chicago, Illinois, United States

and more 12 locations

Serologically Active, Clinically Stable Systemic Lupus Erythematosus

Phase 2
Completed
Conditions
Systemic Lupus Erythematosus
Interventions
Drug: Placebo
First Posted Date
1999-11-04
Last Posted Date
2016-03-04
Lead Sponsor
NYU Langone Health
Target Recruit Count
154
Registration Number
NCT00000421
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Office of Betty Diamond, M.D., Bronx, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

North Shore-Long Island Jewish Health System, New Hyde Park, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Lenox Hill Hospital, New York, New York, United States

Safety of Estrogens in Lupus: Hormone Replacement Therapy

Phase 3
Terminated
Conditions
Systemic Lupus Erythematosus
First Posted Date
1999-11-04
Last Posted Date
2013-05-03
Lead Sponsor
NYU Langone Health
Target Recruit Count
350
Registration Number
NCT00000419
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins Hospital, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago Pritzker School of Medicine, Chicago, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

Univ. of Pittsburgh, Dept. of Rheumatology, Pittsburgh, Pennsylvania, United States

and more 13 locations

Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)

Phase 4
Completed
Conditions
Substance-related Disorders
Dyssocial Behavior
Attention Deficit Disorder With Hyperactivity
First Posted Date
1999-11-03
Last Posted Date
2015-09-29
Lead Sponsor
NYU Langone Health
Registration Number
NCT00000388
ยฉ Copyright 2025. All Rights Reserved by MedPath